Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Stamford Hospital
Stamford, Connecticut, United States
- Eastern Maine Medical Center
Bangor, Maine, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- St. Elizabeth'S Medical Center
Boston, Massachusetts, United States
- Dana-Farber/brigham and Women'S Cancer Center at Milford Regional Medical Center
Milford, Massachusetts, United States
- Dana-Farber/brigham and Women'S Cancer Center in Clinical Affiliation With South Shore Hospital
South Weymouth, Massachusetts, United States
- Dana-Farber/new Hampshire Oncology-Hematology
Londonderry, New Hampshire, United States
- Ohio State University
Columbus, Ohio, United States
- University of Vermont Medical Center
Burlington, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jan 2018
- Primary completion
- 28 Sept 2021
- Completion
- 30 Jul 2026
- Last update posted
- 29 Sept 2025
- Registered enrollment
- 78
- Registry id
- NCT03414684
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.